Your browser doesn't support javascript.
loading
Enhanced immunogenicity of a positively supercharged archaeon thioredoxin scaffold as a cell-penetrating antigen carrier for peptide vaccines.
Cavazzini, Davide; Spagnoli, Gloria; Mariz, Filipe Colaco; Reggiani, Filippo; Maggi, Stefano; Franceschi, Valentina; Donofrio, Gaetano; Müller, Martin; Bolchi, Angelo; Ottonello, Simone.
  • Cavazzini D; Department of Chemistry, Life Sciences & Environmental Sustainability, University of Parma, Parma, Italy.
  • Spagnoli G; Department of Chemistry, Life Sciences & Environmental Sustainability, University of Parma, Parma, Italy.
  • Mariz FC; German Cancer Research Center (DKFZ), Tumorvirus-specific Vaccination Strategies (F035), Heidelberg, Germany.
  • Reggiani F; Department of Chemistry, Life Sciences & Environmental Sustainability, University of Parma, Parma, Italy.
  • Maggi S; Department of Chemistry, Life Sciences & Environmental Sustainability, University of Parma, Parma, Italy.
  • Franceschi V; Department of Veterinary Science, University of Parma, Parma, Italy.
  • Donofrio G; Department of Veterinary Science, University of Parma, Parma, Italy.
  • Müller M; Interdepartmental Center Biopharmanet-Tec, University of Parma, Parma, Italy.
  • Bolchi A; German Cancer Research Center (DKFZ), Tumorvirus-specific Vaccination Strategies (F035), Heidelberg, Germany.
  • Ottonello S; Department of Chemistry, Life Sciences & Environmental Sustainability, University of Parma, Parma, Italy.
Front Immunol ; 13: 958123, 2022.
Article en En | MEDLINE | ID: mdl-36032169
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tiorredoxinas / Archaea / Péptidos de Penetración Celular Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tiorredoxinas / Archaea / Péptidos de Penetración Celular Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article